Why is XERS Down Today?
About Xeris Biopharma Holdings, Inc. Common Stock
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia,...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -2.4%
Market Comparison
🔔 Get XERS Alerts
We'll notify you when XERS's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
XERS has moved more than 3.0% down on 30 occasions in the past year.
Frequently Asked Questions
Why is XERS stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 2.4% on average.
Is XERS stock a buy or sell right now?
Based on current analysis, XERS shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the XERS stock price target?
XERS is currently trading at $9.28. Based on today's momentum, the expected short-term range is $9.00 - $9.46. See long-term price prediction →
Will XERS stock continue falling?
Our analysis shows a 45% probability that XERS's move continues in the next 1-3 days. Key level to watch: $8.81 (support).
Is XERS stock oversold or overbought?
XERS's RSI (Relative Strength Index) is currently at 59.0. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for XERS stock?
XERS's 10-day momentum indicator is at 1.09. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is XERS outperforming or underperforming the market?
XERS (-2.98%) is currently significantly underperforming the market (-3.2% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for XERS?
XERS's MACD (0.33) is currently above the signal line (0.18), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 30.9) is strong.
Is XERS in an uptrend or downtrend?
Based on moving average analysis, XERS is in a bullish trend. The price ($9.28) is trading above both the 20-day SMA ($8.52) and 50-day SMA ($8.44). This alignment typically indicates sustained upward momentum.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis